EpiVario Licenses Cancer-Fighting Compounds in Strategic Move
PHILADELPHIA, PA — EpiVario Inc., a biotechnology firm specializing in neuroepigenetics to treat addiction disorders, announced a significant licensing deal with ReEngage Therapeutics. The agreement involves several of EpiVario’s small …
EpiVario Licenses Cancer-Fighting Compounds in Strategic Move Read More